BRCA1 and breast carcinoma: According to previous research, BRCA1/2 mutation carriers had a higher risk of mortality from breast cancer (HR 1.44, 95% CI: 1.05–1.97) and distant metastases (HR 1.82, 95% CI: 1.05–3.16) than sporadic/BRCA-negative individuals [20].